Stocktoria

ROCKET PHARMACEUTICALS, INC. RCKT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-02-18 · LEI

ROCKET PHARMACEUTICALS, INC. statistics & valuation

Market cap$354.9M
P / B1.3×
Return on equity-80.5%
Return on capital-77.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-90.50% -126.20% -38.40% -25.10% -27.70% -37.20% -45.30% -49.90% -55.90% -80.50% 2016201720182019202020212022202320242025
Shares outstanding
6.7M 6.8M 45.1M 54.8M 61.0M 64.5M 79.1M 90.3M 106.5M 111.1M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-5.80% -97.20% -29.70% -20.80% -23.60% -34.00% -40.20% -43.40% -49.00% -67.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.58 -$2.52 -$2.67 -$3.26 -$2.92 -$2.73 -$2.01 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-67.5%-49.0%-43.4%-40.2%-34.0%-23.6%-20.8%-29.7%-97.2%-5.8%
Return on equity-80.5%-55.9%-49.9%-45.3%-37.2%-27.7%-25.1%-38.4%-126.2%-90.5%
Current ratio6.389.307.809.2917.6914.9416.8113.604.1918.23

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.